EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting p21‐Positive Senescent Chondrocytes via IL‐6R/JAK2 Inhibition to Alleviate Osteoarthritis

Xiang Zhao, Jieming Lin, Feng Liu, Yu Zhang, Bo Shi, Chunhui Ma, Ziqi Wang, Song Xue, Qingrong Xu, Hongda Shao, Jingxing Yang iD, Yanzheng Gao

Advanced Science · 2025-03 · 12 (11)

DOI: 10.1002/advs.202410795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.01.2025. Verfasst von Xiang Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery of Spine and Spinal Cord, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of H…. Hauptthemen laut MEDLINE: Chondrocytes, Janus Kinase 2, Osteoarthritis, Receptors, Interleukin-6. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is an age‐related degenerative joint disease, prominently influenced by the pro‐inflammatory cytokine interleukin‐6 (IL‐6). Although elevated IL‐6 levels in joint fluid are well‐documented, the uneven cartilage degeneration observed in knee OA patients suggests additional underlying mechanisms. This study investigates the role of interleukin‐6 receptor (IL‐6R) in mediating IL‐6 signaling and its contribution to OA progression. Here, significantly elevated IL‐6R expression is identified in degenerated cartilage of OA patients. Further, in vivo experiments reveal that intra‐articular injection of recombinant IL‐6R protein or activation of gp130 (Y757F mutation) accelerates OA progression. Conversely, knockout of IL‐6R or JAK2, as well as treatment with a JAK inhibitor, alleviates OA symptoms. Mechanistically, chondrocytes derived from degenerative cartilage exhibit impaired nuclear localization of SOX9, a key regulator of cartilage homeostasis. JAK inhibition stabilizes SIRT1, reduces SOX9 acetylation, and thereby facilitates SOX9 nuclear localization, promoting cartilage repair. Additionally, the JAK inhibitor‐induced apoptosis in p21‐positive senescent cells, and their targeted clearance successfully alleviates OA in p21‐3MR mice. In conclusion, these findings reveal a novel mechanism by which inhibiting the IL‐6R/JAK2 pathway can alleviate OA. Furthermore, this study proposes targeting p21‐positive senescent cells as a new therapeutic strategy for OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesJanus Kinase 2OsteoarthritisReceptors, Interleukin-6Cyclin-Dependent Kinase Inhibitor p21AnimalsMiceHumansCellular SenescenceInterleukin-6Signal TransductionMaleCartilage, ArticularMice, Inbred C57BL

Stichwörter der Autor:innen

JAK2 signalingcartilage degenerationinterleukin‐6 receptorosteoarthritissenescent cells

Substanzen

Janus Kinase 2Receptors, Interleukin-6Cyclin-Dependent Kinase Inhibitor p21Interleukin-6JAK2 protein, human

Autor:innen und Institutionen

  • Department of Surgery of Spine and Spinal Cord, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No.7 Weiwu Road, Zhengzhou, Henan, 450003, China.
  • Department of Orthopaedics, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 160 Pujian Road, Shanghai, 200127, China.
  • Department of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
  • Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
  • Department of Orthopedic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, 200080, China.
  • Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, 450003, China.

ORCID-Profile: Jingxing Yang

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Zhao, X., Lin, J., Liu, F., Zhang, Y., Shi, B., Ma, C., Wang, Z., Xue, S., Xu, Q., Shao, H., Yang, J., & Gao, Y. (2025). Targeting p21‐Positive Senescent Chondrocytes via IL‐6R/JAK2 Inhibition to Alleviate Osteoarthritis. Advanced Science, 12(11). https://doi.org/10.1002/advs.202410795

Vancouver

Zhao X, Lin J, Liu F, Zhang Y, Shi B, Ma C, et al. Targeting p21‐Positive Senescent Chondrocytes via IL‐6R/JAK2 Inhibition to Alleviate Osteoarthritis. Advanced Science. 2025;12(11). doi:10.1002/advs.202410795

BibTeX
@article{Zhao2025,
  author = {Zhao, Xiang and Lin, Jieming and Liu, Feng and Zhang, Yu and Shi, Bo and Ma, Chunhui and Wang, Ziqi and Xue, Song and Xu, Qingrong and Shao, Hongda and Yang, Jingxing and Gao, Yanzheng},
  title = {Targeting p21‐Positive Senescent Chondrocytes via IL‐6R/JAK2 Inhibition to Alleviate Osteoarthritis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {11},
  doi = {10.1002/advs.202410795}
}
Kostenlos starten →